| Dr Kevin Mcconkey, MD | |
|
920 Church St N, Concord, NC 28025-2927 | |
| (704) 403-3000 | |
| Not Available |
| Full Name | Dr Kevin Mcconkey |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 920 Church St N, Concord, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316434970 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 73125-20 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center-northeast | Concord, NC | Hospital |
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wake Forest Emergency Providers | 7012819816 | 218 |
News Archive
The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 4,003,100 doses of H1N1 flu vaccine to Pennsylvania to date, the state Department of Health said today.
Merus Labs International Inc. is pleased to announce that their wholly owned subsidiary, Merus Labs Inc. announces the execution of a definitive agreement with Innocoll Pharmaceuticals Limited to license in, on an exclusive basis, 3 advanced wound care products for the Canadian market. Furthermore, Innocoll agrees to grant to Merus a right of first refusal for all current pipeline advanced wound care products for the Canadian Market.
"It's March Madness in Congress as well as on the nation's basketball courts this week, so let's look at the past performance charts to see how the two teams have performed on the big challenge of comprehensive healthcare reform.
HEALTHPOINT today announced it will provide a donation to the Association for the Advancement of Wound Care Patient Advocacy Campaign to support 100 free AAWC patient memberships. The AAWC initiative is to be formally launched today during the Opening Ceremony of the Spring 2010 Symposium on Advanced Wound Care, on April 17, 2010, from 2:15-3:00 PM at the Gaylord Palms Hotel and Convention Center in Orlando, FL.
Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.
› Verified 4 days ago
| Entity Name | Wake Forest Emergency Providers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396216735 PECOS PAC ID: 7012819816 Enrollment ID: O20190312003619 |
News Archive
The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 4,003,100 doses of H1N1 flu vaccine to Pennsylvania to date, the state Department of Health said today.
Merus Labs International Inc. is pleased to announce that their wholly owned subsidiary, Merus Labs Inc. announces the execution of a definitive agreement with Innocoll Pharmaceuticals Limited to license in, on an exclusive basis, 3 advanced wound care products for the Canadian market. Furthermore, Innocoll agrees to grant to Merus a right of first refusal for all current pipeline advanced wound care products for the Canadian Market.
"It's March Madness in Congress as well as on the nation's basketball courts this week, so let's look at the past performance charts to see how the two teams have performed on the big challenge of comprehensive healthcare reform.
HEALTHPOINT today announced it will provide a donation to the Association for the Advancement of Wound Care Patient Advocacy Campaign to support 100 free AAWC patient memberships. The AAWC initiative is to be formally launched today during the Opening Ceremony of the Spring 2010 Symposium on Advanced Wound Care, on April 17, 2010, from 2:15-3:00 PM at the Gaylord Palms Hotel and Convention Center in Orlando, FL.
Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Mcconkey, MD 920 Church St N, Concord, NC 28025-2927 Ph: () - | Dr Kevin Mcconkey, MD 920 Church St N, Concord, NC 28025-2927 Ph: (704) 403-3000 |
News Archive
The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 4,003,100 doses of H1N1 flu vaccine to Pennsylvania to date, the state Department of Health said today.
Merus Labs International Inc. is pleased to announce that their wholly owned subsidiary, Merus Labs Inc. announces the execution of a definitive agreement with Innocoll Pharmaceuticals Limited to license in, on an exclusive basis, 3 advanced wound care products for the Canadian market. Furthermore, Innocoll agrees to grant to Merus a right of first refusal for all current pipeline advanced wound care products for the Canadian Market.
"It's March Madness in Congress as well as on the nation's basketball courts this week, so let's look at the past performance charts to see how the two teams have performed on the big challenge of comprehensive healthcare reform.
HEALTHPOINT today announced it will provide a donation to the Association for the Advancement of Wound Care Patient Advocacy Campaign to support 100 free AAWC patient memberships. The AAWC initiative is to be formally launched today during the Opening Ceremony of the Spring 2010 Symposium on Advanced Wound Care, on April 17, 2010, from 2:15-3:00 PM at the Gaylord Palms Hotel and Convention Center in Orlando, FL.
Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.
› Verified 4 days ago
Leonard Alexander Stallings, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 920 Church St N, Concord, NC 28025 Phone: 704-403-1311 | |
Amber Gombash, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 920 Church St N, Concord, NC 28025 Phone: 704-403-3000 | |
Dr. Jon L Hobbs, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1028 Lee Ann Dr Ne, Concord, NC 28025 Phone: 704-782-1892 Fax: 704-786-1890 | |
Neel Andharia, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 920 Church St N, Concord, NC 28025 Phone: 704-403-3000 | |
Dr. Gregory Lawrence Geers, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1028 Lee Ann Dr Ne, Suite 200, Concord, NC 28025 Phone: 704-782-1892 Fax: 704-786-1890 | |
Rachel Price Giller, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 920 Church St N, Concord, NC 28025 Phone: 704-782-9421 | |
John David Franklin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1028 Lee Ann Dr Ne, Ste 200, Concord, NC 28025 Phone: 704-782-1892 Fax: 704-786-1890 |